APOE4 Status and cognitive function in middle-aged and elderly people

1J. Kim, J. M. Basak, and D. M. Holtzman, “The Role of Apolipoprotein E in Alzheimer’s Disease,” Neuron. 2009; 63(3): 287–303,Kim J. Basak J. M. and Holtzman D. M. “The Role of Apolipoprotein E in Alzheimer’s Disease,” Neuron 2009 633 287 30310.1016/j.neuron.2009.06.026304444619679070Search in Google Scholar

2O. MC, M. SE, Z. G, N. AC, and M. CE, “APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review,” Cortex. 2018; 104: 103–123.MC O. SE M. G Z. AC N. and CE M. “APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review,” Cortex 2018 104 103 12310.1016/j.cortex.2018.03.02529800787Search in Google Scholar

3G. Jun et al., “Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region,” Arch Neurol. 2012; 69(10): 1270–1279.Jun G. et al “Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region,” Arch Neurol 2012 6910 1270 127910.1001/archneurol.2012.2052357965922869155Search in Google Scholar

4L. A. Farrer et al., “Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis,” JAMA. 1997; 278(16): 1349–1356.Farrer L. A. et al “Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis,” JAMA 1997 27816 1349 135610.1001/jama.1997.03550160069041Search in Google Scholar

5S. M. Laws, E. Hone, S. Gandy, and R. N. Martins, “Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription,” J. Neurochem. 2003; 84(6): 1215–1236.Laws S. M. Hone E. Gandy S. and Martins R. N. “Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription,” J. Neurochem 2003 846 1215 123610.1046/j.1471-4159.2003.01615.x12614323Search in Google Scholar

6S. Emrani, H. A. Arain, C. DeMarshall, and T. Nuriel, “APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review,” Alzheimers. Res. Ther. 2020; 12(1): 141.Emrani S. Arain H. A. DeMarshall C. and Nuriel T. “APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review,” Alzheimers. Res. Ther 2020 121 14110.1186/s13195-020-00712-4764347933148345Search in Google Scholar

7R. Cacciaglia et al., “Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease,” Alzheimer’s Dement. 2018; 14(7): 902–912.Cacciaglia R. et al “Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease,” Alzheimer’s Dement 2018 147 902 91210.1016/j.jalz.2018.01.01629605385Search in Google Scholar

8K. Chen et al., “Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares,” Neuroimage. 2012; 60(4): 2316.Chen K. et al “Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares,” Neuroimage 2012 604 231610.1016/j.neuroimage.2012.02.005332564222348880Search in Google Scholar

9A. Montagne et al., “APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline,” Nature. 2020; 581(7806): 71–76.Montagne A. et al “APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline,” Nature 2020 5817806 71 7610.1038/s41586-020-2247-3725000032376954Search in Google Scholar

10S. Moreno-Grau et al., “Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results,” 2017.Moreno-Grau S. et al “Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results,” 201710.1016/j.jalz.2017.06.208Search in Google Scholar

11World Medical Association, “Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols,” World Med. Assoc. 2013; 1964: 29–32.World Medical Association “Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols,” World Med. Assoc 2013 1964 29 32Search in Google Scholar

12Diagnostic and statistical manual of mental disorders : DSM-IV. Fourth edition. Washington, DC : American Psychiatric Association, [1994] ©1994.Diagnostic and statistical manual of mental disorders : DSM-IV Fourth edition Washington, DC American Psychiatric Association 1994 ©1994Search in Google Scholar

13M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” J. Psychiatr. Res. 1975; 12(3): 189–198.Folstein M. F. Folstein S. E. and McHugh P. R. “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” J. Psychiatr. Res 1975 123 189 19810.1016/0022-3956(75)90026-61202204Search in Google Scholar

14E. Strauss, E. M. S. Sherman, and O. Spreen, A compendium of neuropsychological tests: Administration, norms, and commentary, 3rd ed. New York, NY, US: Oxford University Press, 2006.Strauss E. Sherman E. M. S. and Spreen O. A compendium of neuropsychological tests: Administration, norms, and commentary, 3rd ed New York, NY, US Oxford University Press 2006Search in Google Scholar

15A. Rey, “L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.],” Arch. Psychol. (Geneve). 1941; 28: 215–285.Rey A. “L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.],” Arch. Psychol. (Geneve) 1941 28 215 285Search in Google Scholar

16Z. Shao, E. Janse, K. Visser, and A. S. Meyer, “What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults,” Front. Psychol. 2014; 5: 1–10.Shao Z. Janse E. Visser K. and Meyer A. S. “What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults,” Front. Psychol 2014 5 1 1010.3389/fpsyg.2014.00772410645325101034Search in Google Scholar

17M. D. Lezak, D. B. Howieson, D. W. Loring, and J. S. Fischer, Neuropsychological assessment. Oxford University Press, USA, 2004.Lezak M. D. Howieson D. B. Loring D. W. and Fischer J. S. Neuropsychological assessment Oxford University Press USA 2004Search in Google Scholar

18L. M. Nichols et al., “Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults,” Arch. Gen. Psychiatry. 2012; 69(8): 804–813.Nichols L. M. et al “Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults,” Arch. Gen. Psychiatry 2012 698 804 81310.1001/archgenpsychiatry.2011.189322868934Search in Google Scholar

19G. A. Rodriguez, M. P. Burns, E. J. Weeber, and G. W. Rebeck, “Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex,” Learn. Mem. 2013; 20(5): 256–266.Rodriguez G. A. Burns M. P. Weeber E. J. and Rebeck G. W. “Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex,” Learn. Mem 2013 205 256 26610.1101/lm.030031.112363048923592036Search in Google Scholar

20T. Iachini, A. Iavarone, V. P. Senese, F. Ruotolo, and G. Ruggiero, “Visuospatial Memory in Healthy Elderly, AD and MCI: A Review,” Curr. Aging Sci. 2009; 2: 43–59.Iachini T. Iavarone A. Senese V. P. Ruotolo F. and Ruggiero G. “Visuospatial Memory in Healthy Elderly, AD and MCI: A Review,” Curr. Aging Sci 2009 2 43 5910.2174/187460981090201004320021398Search in Google Scholar

21R. J. Piers, Y. Liu, T. F. A. Ang, Q. Tao, R. Au, and W. Q. Qiu, “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study,” J. Alzheimer’s Dis. 2021; 80(3): 1269–1279.Piers R. J. Liu Y. Ang T. F. A. Tao Q. Au R. and Qiu W. Q. “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study,” J. Alzheimer’s Dis 2021 803 1269 127910.3233/JAD-200998817207833646152Search in Google Scholar

22F. Mashayekhi, S. Sadigh-Eteghad, A. Naseri, M. Asadi, N. A. Garravnd, and M. Talebi, “ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study,” Neurol. Sci. 2021. 2021; 1–8.Mashayekhi F. Sadigh-Eteghad S. Naseri A. Asadi M. Garravnd N. A. and Talebi M. “ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study,” Neurol. Sci. 2021 2021 1–810.1007/s10072-021-05383-z34120271Search in Google Scholar

23I. Reinvang, T. Espeseth, and L. T. Westlye, “APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease,” Neurosci. Biobehav. Rev. 2013; 37: 1322–1335.Reinvang I. Espeseth T. and Westlye L. T. “APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease,” Neurosci. Biobehav. Rev 2013 37 1322 133510.1016/j.neubiorev.2013.05.00623701948Search in Google Scholar